(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 5.96% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Albemarle's revenue in 2025 is $5,093,671,000.On average, 6 Wall Street analysts forecast ALB's revenue for 2025 to be $571,659,786,462, with the lowest ALB revenue forecast at $540,718,966,551, and the highest ALB revenue forecast at $591,872,166,573. On average, 8 Wall Street analysts forecast ALB's revenue for 2026 to be $629,133,260,141, with the lowest ALB revenue forecast at $569,169,375,556, and the highest ALB revenue forecast at $711,260,225,130.
In 2027, ALB is forecast to generate $722,892,771,393 in revenue, with the lowest revenue forecast at $604,467,649,756 and the highest revenue forecast at $835,274,828,486.